Доступ предоставлен для: Guest
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции
Critical Reviews™ in Eukaryotic Gene Expression
Импакт фактор: 1.841 5-летний Импакт фактор: 1.927 SJR: 0.649 SNIP: 0.516 CiteScore™: 1.96

ISSN Печать: 1045-4403
ISSN Онлайн: 2162-6502

Выпуски:
Том 29, 2019 Том 28, 2018 Том 27, 2017 Том 26, 2016 Том 25, 2015 Том 24, 2014 Том 23, 2013 Том 22, 2012 Том 21, 2011 Том 20, 2010 Том 19, 2009 Том 18, 2008 Том 17, 2007 Том 16, 2006 Том 15, 2005 Том 14, 2004 Том 13, 2003 Том 12, 2002 Том 11, 2001 Том 10, 2000 Том 9, 1999 Том 8, 1998 Том 7, 1997 Том 6, 1996 Том 5, 1995 Том 4, 1994

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukarGeneExpr.v18.i1.60
pages 81-91

Clinical Relevance of Transgenic Mouse Models for Aging Research

L. C. Enns
Department of Comparative Medicine, University of Washington, Seattle, WA 98195, USA
J. C. Wiley
Department of Comparative Medicine, University of Washington, Seattle, WA 98195, USA
W. C. Ladiges
Department of Comparative Medicine, University of Washington, Seattle, WA 98195, USA

Краткое описание

Studies on transgenic mice have shown them to be useful models for human aging- and age-related diseases. Life span end points in yeast and Caenorhabditis elegans can identify highly conserved genes that promote longevity when their functions are lost and which can readily be manipulated in the mouse. Protein kinase A is an example of a highly conserved gene that has age-delaying effects when specific subunits are suppressed or removed in the mouse, suggesting that loss of function may be a rational pharmacologic target. Gain of function is also an attractive clinical approach because expression levels of some vital genes may decrease in an age-related manner. The antioxidant enzyme catalase can delay aging when the human gene is inserted into mitochondria of mice. Other antioxidant genes are of interest in this system, both individually and in combination with catalase. A challenging aspect is to determine how to deliver catalase, as well as other gene products, into the mitochondria in the clinical setting. A number of new and exciting genes will most likely be investigated as clinical antiaging targets as the result of a forward genetic life span screening approach in invertebrates and a reverse genetic life span approach in the mouse.


Articles with similar content:

Glucocorticoid-Induced Apoptosis in Animal Models of Multiple Sclerosis
Critical Reviews™ in Immunology, Vol.33, 2013, issue 3
Marco J. Herold, Holger Reichardt
Retinoid Targets for the Treatment of Cancer
Critical Reviews™ in Eukaryotic Gene Expression, Vol.16, 2006, issue 3
Dianne Robert Soprano, Zivjena Buletic, Kenneth J. Soprano
In Utero Exposure and Breast Cancer Development: an Epigenetic Perspective
Journal of Environmental Pathology, Toxicology and Oncology, Vol.33, 2014, issue 3
Jacob Hill, Wendy Hodsdon
Interrelationships between Radiation-Induced Mutations and Modifications in Gene Expression Linked to Cancer
Critical Reviews™ in Eukaryotic Gene Expression, Vol.8, 1998, issue 3-4
Howard L. Liber, Eric N. Phillips
RUNX3-Mediated Immune Cell Development and Maturation
Critical Reviews™ in Immunology, Vol.38, 2018, issue 1
Istvan Szatmari, Tamas Imre Csuth, Pal Boto